Table 4.
LSOCA* | Beaver Dam Offspring Study† | |||
---|---|---|---|---|
Age (years) | Number participants | % with AMD‡ | Number participants | % with AMD‡ |
21–34 | 244 | 5.3 | 168 | 0.6 |
35–44 | 782 | 5.9 | 822 | 1.3 |
45–54 | 605 | 12.9 | 1047 | 3.0 |
55–64 | 150 | 21.3 | 599 | 5.7 |
65–84 | 29 | 34.5 | 174 | 9.2 |
Total | 1810 | 9.9 | 2810 | 3.3 |
Adjusted prevalences | ||||
Age-adjusted | 12.1 | 2.9 | ||
Age- and gender-adjusted | 13.0 | 3.2 | ||
Age- and gender-adjusted, whites only | 11.4 | 3.3 |
LSOCA = Longitudinal Study of the Ocular Complications of AIDS. Excludes 15 participants age ≤20 years, as this age group was not evaluated in the Beaver Dam Offspring Study.
Data from reference 21, Klein R, Cruickshanks KJ, Nash SD, et al. The prevalence of age-related macular degeneration and associated risk factors Arch Ophthalmol 2012;128:750–758.
AMD = age-related macular degeneration; % with intermediate-stage AMD reported.